Effect of vildagliptin compared to glimepiride on postprandial proinsulin processing in the β cell of patients with type 2 diabetes mellitus

Diabetes, Obesity and Metabolism

Volumn 15, Issue 6, 2013, Pages 576-579

  Forst, T ^a,b   Dworak, M ^c   Berndt Zipfel, C ^a   Loffler A ^a   Klamp, I ^a   Mitry, M ^a   Pfutzner A ^a  

^a Institute for Clinical Research and Development   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Novartis Pharma GmbH   (Germany)

Author keywords

DPP IV inhibitor; Intact proinsulin; Sulphonylurea; Type 2 diabetes mellitus; cell function

Indexed keywords

ADIPONECTIN; GLIMEPIRIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; PROINSULIN; VILDAGLIPTIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CELL FUNCTION; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PANCREAS ISLET BETA CELL; PARALLEL DESIGN; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; TEST MEAL;

EID: 84877618486     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12063     Document Type: Article

References (12)

1. Bryhni B, Arnesen E, Jenssen TG. Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study. BMC Endocr Disord 2010; 10: 21.
2. Alssema M, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ. Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: an 11-year follow-up of the Hoorn Study. Diabetes Care 2005; 28: 860-865.
3. Zethelius B, Lithell H, Hales CN, Berne C. Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp. Int J Obes Relat Metab Disord 2005; 48: 862-867.
4. Ahren B, Pacini G, Tura A, Foley JE, Schweizer A. Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes. Horm Metab Res 2007; 39: 826-829.
5. Pratley RE, Schweizer A, Rosenstock J et al. Robust improvements in fasting and prandial measures of β-cell function with vildagliptin in drug-naive patients: analysis of pooled vildagliptin monotherapy database. Diabetes Obes Metab 2008; 10: 931-938.
6. DelPrato S, Barnett AH, Huisman H, Neubacher D, Woerle HJ, Dugi KA. Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. Diabetes Obes Metab 2011; 13: 258-267.
7. Fritsche A, Madaus A, Stefan N et al. Relationships among age, proinsulin conversion, and β-cell function in nondiabetic humans. Diabetes 2002; 51(Suppl 1): S234-239.
8. Pscherer S, Larbig M, von SB, Pfutzner A, Forst T. In type 2 diabetes patients, insulin glargine is associated with lower postprandial release of intact proinsulin compared with sulfonylurea treatment. J Diabetes Sci Technol 2012; 6: 634-640.
9. Lyon CJ, Hsueh WA. Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease. Am J Med 2003; 115(Suppl 8A): 62S-68S.
10. Malaguarnera R, Sacco A, Voci C, Pandini G, Vigneri R, Belfiore A. Proinsulin binds with high affinity the insulin receptor isoform A and predominantly activates the mitogenic pathway. Endocrinology 2012; 153: 2152-2163.
11. Rathmann W, Kostev K, Gruenberger JB, Dworak M, Bader G, Giani G. Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis. Diabetes Obes Metab 2012; 15: 55-61.
12. Gallwitz B, Rosenstock J, Rauch T et al. 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial. Lancet 2012; 380: 475-483.